Purdue Pharma and its controlling Sackler family have offered a new settlement to resolve lawsuits over their involvement in the opioid epidemic, raising the payout from the Sacklers to $6 billion.

A judge in the US has approved the sale of Purdue Pharma’s consumer ... still trying to get its settlement offer over the line more than a year after raising the payout. It is still facing ...

Nearly 22,000 pounds of fentanyl were seized at US borders during the 2024 fiscal year, according to data from the US Customs ...

Peoples Gas’ System Modernization Program (SMP) is an expensive, ecologically destructive disaster disguised as a safety ...

Oxycontin gets approved right at the end of 1995, it hits the market in 1996 – and within five years, it’s brought in revenues of $2.8 billion for Purdue Pharma. And a big part of that is down ...

“We’re on the frontier of Pharma 4.0 — autonomous experimentation, advanced robotics, big data, smart factories, AI and machine learning,” said Karen Plaut, Purdue’s executive vice president for ...

Ascendis Pharma (ASND) announced that its board of ... In addition, the company plans to apply net settlement of the tax-withholding obligation in certain jurisdictions related to the vesting ...

In addition, the Company plans to apply net settlement of the tax-withholding ... terminated at any time without notice. About Ascendis Pharma A/S Ascendis Pharma is applying its innovative ...

Ascendis Pharma A/S announced that its Board of Directors approved a plan to allocate approximately $25 million in the first quarter of 2025 for a share repurchase program and the net settlement ...